Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 24117507)

1.

Implication of novel bis-imidazopyridines for management of Alzheimer's disease and establishment of its role on protein phosphatase 2A activity in brain.

Parekh KD, Dash RP, Pandya AN, Vasu KK, Nivsarkar M.

J Pharm Pharmacol. 2013 Dec;65(12):1785-95. doi: 10.1111/jphp.12149. Epub 2013 Oct 7.

PMID:
24117507
2.

Role of protein phosphatase 2A in Alzheimer's disease.

Rudrabhatla P, Pant HC.

Curr Alzheimer Res. 2011 Sep;8(6):623-32. Review.

PMID:
21605044
3.

Effect of some medicinal plant extracts on the oxidative stress status in Alzheimer's disease induced in rats.

Mahdy K, Shaker O, Wafay H, Nassar Y, Hassan H, Hussein A.

Eur Rev Med Pharmacol Sci. 2012 Jul;16 Suppl 3:31-42.

PMID:
22957416
4.

Molecular implication of PP2A and Pin1 in the Alzheimer's disease specific hyperphosphorylation of Tau.

Landrieu I, Smet-Nocca C, Amniai L, Louis JV, Wieruszeski JM, Goris J, Janssens V, Lippens G.

PLoS One. 2011;6(6):e21521. doi: 10.1371/journal.pone.0021521. Epub 2011 Jun 23.

5.

Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models.

van Eersel J, Ke YD, Liu X, Delerue F, Kril JJ, Götz J, Ittner LM.

Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13888-93. doi: 10.1073/pnas.1009038107. Epub 2010 Jul 19.

6.

Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.

Zhou XW, Gustafsson JA, Tanila H, Bjorkdahl C, Liu R, Winblad B, Pei JJ.

Neurobiol Dis. 2008 Sep;31(3):386-94. doi: 10.1016/j.nbd.2008.05.013. Epub 2008 Jul 23.

PMID:
18586097
7.

Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.

Gong CX, Grundke-Iqbal I, Iqbal K.

Neuroscience. 1994 Aug;61(4):765-72.

PMID:
7838376
9.

Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease.

Tanimukai H, Grundke-Iqbal I, Iqbal K.

Am J Pathol. 2005 Jun;166(6):1761-71.

10.

Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease.

Voronkov M, Braithwaite SP, Stock JB.

Future Med Chem. 2011 May;3(7):821-33. doi: 10.4155/fmc.11.47. Review.

11.

Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease.

Aly HF, Metwally FM, Ahmed HH.

Acta Biochim Pol. 2011;58(4):513-20. Epub 2011 Dec 6.

12.

Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.

Corcoran NM, Martin D, Hutter-Paier B, Windisch M, Nguyen T, Nheu L, Sundstrom LE, Costello AJ, Hovens CM.

J Clin Neurosci. 2010 Aug;17(8):1025-33. doi: 10.1016/j.jocn.2010.04.020. Epub 2010 May 26.

PMID:
20537899
13.

PTPA activates protein phosphatase-2A through reducing its phosphorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B.

Luo Y, Nie YJ, Shi HR, Ni ZF, Wang Q, Wang JZ, Liu GP.

Biochim Biophys Acta. 2013 May;1833(5):1235-43. doi: 10.1016/j.bbamcr.2013.02.005. Epub 2013 Feb 19.

14.

Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.

Arif M, Kazim SF, Grundke-Iqbal I, Garruto RM, Iqbal K.

Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1144-9. doi: 10.1073/pnas.1322614111. Epub 2014 Jan 6.

15.

Alpha-chymotrypcin ameliorates neuroinflammation and apoptosis characterizing Alzheimer's disease-induced in ovarictomized rats.

El Dayem SM, Ahmed HH, Metwally F, Foda FM, Shalby AB, Zaazaa AM.

Exp Toxicol Pathol. 2013 Jul;65(5):477-83. doi: 10.1016/j.etp.2012.02.002. Epub 2012 Mar 30.

PMID:
22464639
16.

Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus.

Zhang CE, Tian Q, Wei W, Peng JH, Liu GP, Zhou XW, Wang Q, Wang DW, Wang JZ.

Neurobiol Aging. 2008 Nov;29(11):1654-65. Epub 2007 May 29.

PMID:
17537547
17.

Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.

Calabrese V, Butterfield DA, Stella AM.

Ital J Biochem. 2003 Dec;52(4):177-81. Review.

PMID:
15141484
18.

How it all started: tau and protein phosphatase 2A.

Liu C, Götz J.

J Alzheimers Dis. 2013;37(3):483-94. doi: 10.3233/JAD-130503. Review.

PMID:
23948891
19.

Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.

Xiong Y, Jing XP, Zhou XW, Wang XL, Yang Y, Sun XY, Qiu M, Cao FY, Lu YM, Liu R, Wang JZ.

Neurobiol Aging. 2013 Mar;34(3):745-56. doi: 10.1016/j.neurobiolaging.2012.07.003. Epub 2012 Aug 11.

PMID:
22892311
20.

Nmnat2 attenuates Tau phosphorylation through activation of PP2A.

Cheng XS, Zhao KP, Jiang X, Du LL, Li XH, Ma ZW, Yao J, Luo Y, Duan DX, Wang JZ, Zhou XW.

J Alzheimers Dis. 2013;36(1):185-95. doi: 10.3233/JAD-122173.

PMID:
23579329
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk